Actively Recruiting
Randomized Trial of Suzetrigine Compared to Placebo for Pain and Opioid Use in Total Knee Replacement Surgery
Led by Hospital for Special Surgery, New York · Updated on 2026-10-13
148
Participants Needed
1
Research Sites
52 weeks
Total Duration
AI-Summary
What This Trial Is About
Researchers are studying the effects of suzetrigine, a new non-opioid pain medication, in patients undergoing primary total knee replacement surgery. This phase III trial aims to assess whether suzetrigine can reduce opioid use and improve pain management during the recovery period, addressing the challenges of opioid-related side effects and dependency in this common and painful orthopedic procedure. The study is sponsored by the Hospital for Special Surgery, New York. Participants will be randomly assigned to receive either suzetrigine or a placebo for 14 days, beginning with a loading dose before surgery. The study uses a triple-blind design and includes multiple assessments of pain, opioid consumption, sleep quality, patient satisfaction, and other recovery-related measures over a 12-week period. Additional evaluations include knee function, range of motion, and the incidence of adverse events. During the trial, participants will undergo regular monitoring including pain assessments at rest and with movement, opioid and non-opioid analgesic use tracking, and questionnaires on sleep and satisfaction. Measurements occur from surgery through post-operative day 14, with further follow-ups at 6 and 12 weeks. The primary outcome is the total opioid consumption within the first 48 hours after surgery. Safety and effectiveness will be closely monitored throughout the study, which lasts up to several months post-surgery.
CONDITIONS
Brief Title
Suzetrigine in TKA
Research Team
C
Curtis Weh, B.S.
H
Hannah Gerner, MD
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here